271 related articles for article (PubMed ID: 34024060)
1. [COVID-19 Vaccination for Cancer Patients: Progress and Preliminary Recommendations].
Wang L; Xu Y; Zhang L; Fan J; Pan R; Wang J; Wang M
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):377-383. PubMed ID: 34024060
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
3. Understanding COVID-19 in Africa.
Tessema SK; Nkengasong JN
Nat Rev Immunol; 2021 Aug; 21(8):469-470. PubMed ID: 34168345
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccinations: The unknowns, challenges, and hopes.
Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccination in our transplant recipients: The time is now.
Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
[TBL] [Abstract][Full Text] [Related]
6. Balancing the Risks and Benefits of COVID-19 Vaccination for Pregnant Women and Their Children.
Yang C; Zhao H; Tebbutt SJ
Front Immunol; 2021; 12():748456. PubMed ID: 34975839
[No Abstract] [Full Text] [Related]
7. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
Tran S; Truong TH; Narendran A
Eur J Cancer; 2021 Dec; 159():259-274. PubMed ID: 34798454
[TBL] [Abstract][Full Text] [Related]
9. Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
Hupert N; Marín-Hernández D; Gao B; Águas R; Nixon DF
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012976
[TBL] [Abstract][Full Text] [Related]
10. Indications for and contraindications of immune checkpoint inhibitors in cancer patients with COVID-19 vaccination.
Luo B; Li J; Hou X; Yang Q; Zhou Y; Ye J; Wu X; Feng Y; Hu T; Xu Z; He Y; Sun J
Future Oncol; 2021 Sep; 17(26):3477-3484. PubMed ID: 34189948
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
Cevik M; Grubaugh ND; Iwasaki A; Openshaw P
Cell; 2021 Sep; 184(20):5077-5081. PubMed ID: 34534444
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.
Becerril-Gaitan A; Vaca-Cartagena BF; Ferrigno AS; Mesa-Chavez F; Barrientos-Gutiérrez T; Tagliamento M; Lambertini M; Villarreal-Garza C
Eur J Cancer; 2022 Jan; 160():243-260. PubMed ID: 34794855
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of Pregnant Women Against COVID-19.
Abu-Raya B
Neoreviews; 2021 Sep; 22(9):e570-e573. PubMed ID: 34470758
[TBL] [Abstract][Full Text] [Related]
14. Cancer Centers, Organizations Call for COVID-19 Vaccine for Patients With Cancer, Survivors.
Printz C
Cancer; 2021 Apr; 127(8):1170-1171. PubMed ID: 33878201
[No Abstract] [Full Text] [Related]
15. Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters.
O'Donnell KL; Clancy CS; Griffin AJ; Shifflett K; Gourdine T; Thomas T; Long CM; Furuyama W; Marzi A
Front Immunol; 2021; 12():788235. PubMed ID: 35069564
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.
Griffiths EA; Segal BH
Cancer Cell; 2021 Aug; 39(8):1045-1047. PubMed ID: 34242573
[TBL] [Abstract][Full Text] [Related]
17. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
18. Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.
Romano E; Pascolo S; Ott P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34117117
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
Front Immunol; 2021; 12():728021. PubMed ID: 34646267
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8
Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T
Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
